1. Home
  2. CYTK vs GPOR Comparison

CYTK vs GPOR Comparison

Compare CYTK & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • GPOR
  • Stock Information
  • Founded
  • CYTK 1997
  • GPOR 1997
  • Country
  • CYTK United States
  • GPOR United States
  • Employees
  • CYTK N/A
  • GPOR N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • GPOR Oil & Gas Production
  • Sector
  • CYTK Health Care
  • GPOR Energy
  • Exchange
  • CYTK Nasdaq
  • GPOR Nasdaq
  • Market Cap
  • CYTK 4.6B
  • GPOR 3.9B
  • IPO Year
  • CYTK 2004
  • GPOR N/A
  • Fundamental
  • Price
  • CYTK $60.16
  • GPOR $201.91
  • Analyst Decision
  • CYTK Strong Buy
  • GPOR Buy
  • Analyst Count
  • CYTK 15
  • GPOR 10
  • Target Price
  • CYTK $76.73
  • GPOR $216.22
  • AVG Volume (30 Days)
  • CYTK 1.7M
  • GPOR 256.5K
  • Earning Date
  • CYTK 11-05-2025
  • GPOR 11-04-2025
  • Dividend Yield
  • CYTK N/A
  • GPOR N/A
  • EPS Growth
  • CYTK N/A
  • GPOR N/A
  • EPS
  • CYTK N/A
  • GPOR N/A
  • Revenue
  • CYTK $87,211,000.00
  • GPOR $1,231,668,000.00
  • Revenue This Year
  • CYTK $363.61
  • GPOR $53.98
  • Revenue Next Year
  • CYTK $64.33
  • GPOR $11.86
  • P/E Ratio
  • CYTK N/A
  • GPOR N/A
  • Revenue Growth
  • CYTK 2609.26
  • GPOR 38.91
  • 52 Week Low
  • CYTK $29.31
  • GPOR $151.32
  • 52 Week High
  • CYTK $64.13
  • GPOR $210.32
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 55.21
  • GPOR 70.83
  • Support Level
  • CYTK $58.05
  • GPOR $178.66
  • Resistance Level
  • CYTK $61.29
  • GPOR $204.06
  • Average True Range (ATR)
  • CYTK 2.60
  • GPOR 6.58
  • MACD
  • CYTK -0.48
  • GPOR 1.65
  • Stochastic Oscillator
  • CYTK 57.88
  • GPOR 90.83

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

Share on Social Networks: